Buchu is recognised as South Africa's most valuable medicinal plant and could be a challenging method when combating cancer as it aids in stopping chronic inflammation. Chronic inflammation is a concern as it can predispose an individual to cancer.
Professor Patrick Bouic, independent researcher for Cape Kingdom Nutraceuticals says that “Chronic inflammation is due to the presence of diverse cells that secrete very different inflammatory factors.” These factors trigger genes which can lead to the transformation of cells or the activation of oncogenes – a gene that has the potential to cause cancer.
Some of the most common cancers linked to chronic inflammation include lymphoid cancer (lymphoma and leukaemia), prostate cancer and breast cancer. Buchu is endemic to the Western Cape of South Africa, it is a potent natural anti-inflammatory with no harmful side-effects. “To date research has shown that Buchu contains molecules that aid in stopping both acute as well as chronic inflammation. It has shown to ‘switch-off’ the genes leading to the release of inflammatory factors linked with chronic status by inflammatory cells,” explains Bouic when asked how Buchu can assist with managing inflammation.
Bouic stated, “We should never say that it can cure cancer in a solitary state, but added to drugs that stop cell division, it could be a formidable approach to beating cancer. Buchu will stop the release of the inflammatory factors that feed the cancer while registered anti-cancer drugs will prevent the transformed cells from dividing.”